Osteoporosis Associated With Megestrol Acetate
Open Access
- 31 December 2004
- journal article
- case report
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 79 (12) , 1557-1561
- https://doi.org/10.4065/79.12.1557
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Glucocorticoid-Induced Osteoporosis: Summary of a WorkshopJournal of Clinical Endocrinology & Metabolism, 2001
- Prevention and Treatment of Osteoporosis in Women With Breast CancerMayo Clinic Proceedings, 2000
- Aseptic Necrosis in HIV Seropositive Patients: A Possible Etiologic Role for Megestrol AcetateAIDS Patient Care and STDs, 2000
- Glucocorticoidlike activity of megestrol. A summary of Food and Drug Administration experience and a review of the literatureArchives of internal medicine (1960), 1997
- Progesterone stimulates proliferation and differentiation of osteoprogenitor cells in bone cell populations derived from adult female but not from adult male ratsBone, 1997
- Megestrol‐induced Cushing's syndromeClinical Endocrinology, 1995
- Adrenal steroids as parameters of the bioavailability of MA and MPAEuropean Journal of Cancer and Clinical Oncology, 1990
- A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effectsEuropean Journal of Cancer and Clinical Oncology, 1984
- Glucocorticoid properties op progestogensSteroids, 1973